Dr Michael Buschle
Advisor to HBM Partners
More than 25 years of experience in biotech and pharma. PhD from the University of London. Research at St. Jude’s Children’s Research Hospital, Boehringer Ingelheim-owned Institute of Molecular Pathology, Vienna. Industrial experience: Boehringer Ingelheim, Co-founder of Intercell with successful IPO, Chief Scientific Officer of Glenmark Pharmaceuticals.